Liquidia Technologies (LQDA) Competitors $16.60 +1.50 (+9.93%) Closing price 04:00 PM EasternExtended Trading$16.60 0.00 (0.00%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LQDA vs. BLCO, IRTC, SLNO, TMDX, INSP, NVST, PRCT, WRBY, LIVN, and EYEShould you be buying Liquidia Technologies stock or one of its competitors? The main competitors of Liquidia Technologies include Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), LivaNova (LIVN), and National Vision (EYE). These companies are all part of the "medical equipment" industry. Liquidia Technologies vs. Its Competitors Bausch + Lomb iRhythm Technologies Soleno Therapeutics TransMedics Group Inspire Medical Systems Envista PROCEPT BioRobotics Warby Parker LivaNova National Vision Liquidia Technologies (NASDAQ:LQDA) and Bausch + Lomb (NYSE:BLCO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations. Does the media favor LQDA or BLCO? In the previous week, Bausch + Lomb had 1 more articles in the media than Liquidia Technologies. MarketBeat recorded 3 mentions for Bausch + Lomb and 2 mentions for Liquidia Technologies. Bausch + Lomb's average media sentiment score of 0.94 beat Liquidia Technologies' score of 0.21 indicating that Bausch + Lomb is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Liquidia Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Bausch + Lomb 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate LQDA or BLCO? Liquidia Technologies currently has a consensus price target of $26.89, suggesting a potential upside of 61.98%. Bausch + Lomb has a consensus price target of $15.45, suggesting a potential upside of 7.96%. Given Liquidia Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Liquidia Technologies is more favorable than Bausch + Lomb.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Liquidia Technologies 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00Bausch + Lomb 1 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.17 Which has stronger valuation & earnings, LQDA or BLCO? Liquidia Technologies has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Liquidia Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLiquidia Technologies$14M101.37-$130.39M-$1.58-10.51Bausch + Lomb$4.79B1.06-$317M-$1.03-13.90 Which has more risk & volatility, LQDA or BLCO? Liquidia Technologies has a beta of -0.01, meaning that its stock price is 101% less volatile than the S&P 500. Comparatively, Bausch + Lomb has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500. Do institutionals and insiders hold more shares of LQDA or BLCO? 64.5% of Liquidia Technologies shares are held by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are held by institutional investors. 30.1% of Liquidia Technologies shares are held by company insiders. Comparatively, 0.2% of Bausch + Lomb shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is LQDA or BLCO more profitable? Bausch + Lomb has a net margin of -7.50% compared to Liquidia Technologies' net margin of -903.80%. Bausch + Lomb's return on equity of 2.62% beat Liquidia Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Liquidia Technologies-903.80% -177.91% -60.15% Bausch + Lomb -7.50%2.62%1.28% SummaryLiquidia Technologies beats Bausch + Lomb on 9 of the 17 factors compared between the two stocks. Get Liquidia Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LQDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LQDA vs. The Competition Export to ExcelMetricLiquidia TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.29B$2.93B$5.49B$9.45BDividend YieldN/A2.49%4.01%4.03%P/E Ratio-10.5120.5328.3319.89Price / Sales101.37267.80409.3186.86Price / CashN/A41.6635.9658.29Price / Book18.247.808.325.67Net Income-$130.39M-$55.10M$3.24B$258.18M7 Day Performance14.40%6.40%4.20%3.92%1 Month Performance26.04%16.84%10.16%14.31%1 Year Performance46.13%3.12%34.69%17.29% Liquidia Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LQDALiquidia Technologies3.2718 of 5 stars$16.60+9.9%$26.89+62.0%+36.3%$1.29B$14M-10.5150High Trading VolumeBLCOBausch + Lomb2.414 of 5 stars$13.67-1.5%$15.45+13.1%-18.0%$4.83B$4.83B-13.2713,500IRTCiRhythm Technologies1.3401 of 5 stars$138.91+2.2%$138.60-0.2%+36.9%$4.43B$591.84M-44.242,000SLNOSoleno Therapeutics4.6784 of 5 stars$82.76+1.5%$108.70+31.3%+85.2%$4.17BN/A-17.9130High Trading VolumeTMDXTransMedics Group2.2841 of 5 stars$116.88+3.9%$127.33+8.9%-29.6%$3.95B$441.54M85.94210INSPInspire Medical Systems4.8311 of 5 stars$130.17-0.1%$211.91+62.8%-12.9%$3.84B$802.80M59.981,246Positive NewsAnalyst ForecastNVSTEnvista3.5132 of 5 stars$20.05-0.8%$20.23+0.9%+17.5%$3.40B$2.51B-3.0712,300PRCTPROCEPT BioRobotics2.6282 of 5 stars$58.17+2.7%$87.50+50.4%-15.4%$3.22B$249.12M-34.22430WRBYWarby Parker2.8823 of 5 stars$23.02+3.7%$22.88-0.6%+54.2%$2.41B$795.09M-191.803,780Positive NewsInsider TradeLIVNLivaNova3.3563 of 5 stars$43.97-0.8%$59.29+34.8%-20.0%$2.40B$1.25B-10.752,900Positive NewsEYENational Vision2.9176 of 5 stars$25.01+2.2%$22.10-11.6%+93.1%$1.98B$1.82B-75.7913,411Positive News Related Companies and Tools Related Companies Bausch + Lomb Competitors iRhythm Technologies Competitors Soleno Therapeutics Competitors TransMedics Group Competitors Inspire Medical Systems Competitors Envista Competitors PROCEPT BioRobotics Competitors Warby Parker Competitors LivaNova Competitors National Vision Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LQDA) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LQDA Stock Alerts